Diabetes & metabolic generics
DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 agonists and insulin analogues — the highest-volume chronic therapy in the region.
11 molecules. Open any card for the full monograph and price table.
Sitagliptin High demand
Originator: Januvia · Merck Sharp & Dohme (MSD), a subsidiary of Merck & Co., Inc.
US (FDA): adjunct to diet and exercise to improve glycemic control in adults with type 2 diabete
from BDT 13 (US$0.11 / 50 mg) · 20manufacturers
Diabetes & metabolic →
Vildagliptin
Originator: Galvus · Novartis
EU (EMA / UK SmPC): treatment of type 2 diabetes mellitus in adults as monotherapy in patients i
from BDT 12 (US$0.10 / 50 mg) · 22manufacturers
Diabetes & metabolic →
Linagliptin
Originator: Tradjenta · Boehringer Ingelheim (marketed in the US by Boehringer Ingelheim Pharmaceuticals, Inc.; co-promoted with Eli Lilly in several markets)
US (FDA): adjunct to diet and exercise to improve glycemic control in adults with type 2 diabete
from BDT 6 (US$0.05 / 5 mg) · 39manufacturers
Diabetes & metabolic →
Dapagliflozin High demand
Originator: Forxiga · AstraZeneca (originally developed with Bristol-Myers Squibb)
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes me
from BDT 10 (US$0.08 / 5 mg) · 8manufacturers
Diabetes & metabolic →
Empagliflozin High demand
Originator: Jardiance · Boehringer Ingelheim, co-marketed with Eli Lilly and Company (licensed from Boehringer Ingelheim International GmbH)
To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with
from BDT 12 (US$0.10 / 10 mg) · 35manufacturers
Diabetes & metabolic →
Canagliflozin
Originator: Invokana · Janssen Pharmaceuticals (Johnson & Johnson), licensed from Mitsubishi Tanabe Pharma
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes me
from BDT 40 (US$0.33 / 100 mg) · 4manufacturers
Diabetes & metabolic →
Pioglitazone
Originator: Actos; Actoplus Met and Actoplus Met XR · Takeda Pharmaceutical Company (first US approval 1999)
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes me
from BDT 5.07 (US$0.04 / 15 mg) · 15manufacturers
Diabetes & metabolic →
Liraglutide
Originator: Victoza · Novo Nordisk
As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients
Diabetes & metabolic →
Insulin Glargine High demand
Originator: Lantus · Sanofi
To improve glycemic control in adult and pediatric patients with diabetes mellitus (Lantus, US l
Diabetes & metabolic →
Insulin Degludec
Originator: Tresiba · Novo Nordisk
To improve glycemic control in adults with diabetes mellitus (US label of 2015)
Diabetes & metabolic →
Insulin Aspart
Originator: NovoRapid · Novo Nordisk
To improve glycemic control in adults and children with diabetes mellitus (NovoLog, US label)
Diabetes & metabolic →
Therapeutic areas
Medical and legal notice
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.